Literature DB >> 20145955

Hemolytic uremic syndrome caused by Bordetella pertussis infection.

Swasti Chaturvedi1, Christoph Licht, Valerie Langlois.   

Abstract

We report the case of a 4-week-old infant with severe Bordetella pertussis infection resulting in hemolytic anemia, thrombocytopenia, and acute renal failure leading to a diagnosis of hemolytic uremic syndrome (HUS) associated with pertussis. In addition to antibiotic and supportive therapy, he was treated with plasma transfusions based on the possibility of underlying complement defect, and he improved. The association of B. pertussis infection and HUS has previously been described in a patient with a mutation in the gene encoding complement factor H (CFH). However, whereas a genetic workup for complement regulator mutations was performed, no mutation was found in our patient. This case demonstrates the possible association between pertussis infection and HUS and highlights the need for increased vigilance for renal complications in this diagnosis. Despite negative results in this case, in-depth workup of the complement system may be important to guide treatment efforts and strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145955     DOI: 10.1007/s00467-010-1449-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

Review 1.  The virulence factors of Bordetella pertussis: a matter of control.

Authors:  A M Smith; C A Guzmán; M J Walker
Journal:  FEMS Microbiol Rev       Date:  2001-05       Impact factor: 16.408

2.  Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Authors:  Gema Ariceta; Nesrin Besbas; Sally Johnson; Diana Karpman; Daniel Landau; Christoph Licht; Chantal Loirat; Carmine Pecoraro; C Mark Taylor; Nicole Van de Kar; Johan Vandewalle; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2008-09-18       Impact factor: 3.714

3.  Proinflammatory and proapoptotic activities associated with Bordetella pertussis filamentous hemagglutinin.

Authors:  T Abramson; H Kedem; D A Relman
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

Review 4.  Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome.

Authors:  Phillip I Tarr; Carrie A Gordon; Wayne L Chandler
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

5.  Hemolytic uremic syndrome due to an altered factor H triggered by neonatal pertussis.

Authors:  Reinhard Berner; Martin F Krause; Nader Gordjani; Peter F Zipfel; Norbert Boehm; Marcus Krueger; Matthias Brandis; Lothar B Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2002-03       Impact factor: 3.714

Review 6.  Health burden of pertussis in infants and children.

Authors:  David P Greenberg; Carl-Heinz Wirsing von König; Ulrich Heininger
Journal:  Pediatr Infect Dis J       Date:  2005-05       Impact factor: 2.129

Review 7.  Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome.

Authors:  P E Ray; X H Liu
Journal:  Pediatr Nephrol       Date:  2001-10       Impact factor: 3.714

8.  Bordetella pertussis adenylate cyclase toxin (ACT) induces cyclooxygenase-2 (COX-2) in murine macrophages and is facilitated by ACT interaction with CD11b/CD18 (Mac-1).

Authors:  Darren J Perkins; Mary C Gray; Erik L Hewlett; Stefanie N Vogel
Journal:  Mol Microbiol       Date:  2007-10-10       Impact factor: 3.501

Review 9.  Pertussis in early infancy: disease burden and preventive strategies.

Authors:  Peter McIntyre; Nicholas Wood
Journal:  Curr Opin Infect Dis       Date:  2009-06       Impact factor: 4.915

Review 10.  Hemolytic uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

View more
  4 in total

1.  Hemolytic uremic syndrome associated with Bordetella pertussis infection in a 2-month-old infant carrying a pathogenic variant in complement factor H.

Authors:  Iona Madden; Lubka T Roumenina; Hélène Langlois-Meurinne; Julie Guichoux; Brigitte Llanas; Véronique Frémeaux-Bacchi; Jérôme Harambat; Astrid Godron-Dubrasquet
Journal:  Pediatr Nephrol       Date:  2018-12-17       Impact factor: 3.714

Review 2.  Novel developments in thrombotic microangiopathies: is there a common link between hemolytic uremic syndrome and thrombotic thrombocytic purpura?

Authors:  Peter F Zipfel; Gunter Wolf; Ulrike John; Karim Kentouche; Christine Skerka
Journal:  Pediatr Nephrol       Date:  2011-06-14       Impact factor: 3.714

3.  Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome.

Authors:  Lambertus van den Heuvel; Kristian Riesbeck; Omaima El Tahir; Valentina Gracchi; Mariann Kremlitzka; Servaas A Morré; A Marceline van Furth; Birendra Singh; Marcin Okrój; Nicole van de Kar; Anna M Blom; Elena Volokhina
Journal:  J Hum Genet       Date:  2017-11-13       Impact factor: 3.172

4.  Treatment of hemolytic uremic syndrome related to Bordetella pertussis infection -is plasma exchange or eculizumab use necessary?

Authors:  Ken Saida; Masao Ogura; Yuji Kano; Shingo Ishimori; Takahisa Yoshikawa; Hiroko Nagata; Mai Sato; Koichi Kamei; Kenji Ishikura
Journal:  BMC Nephrol       Date:  2018-12-17       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.